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ABSTRACT 
Objectives: This review evaluates the diagnostic ability of Kidney Injury Molecule 1 (Kim-1) in various clinical conditions.  
Methods: We screened literature in electronic database from January 2016 to March 2016 by the words “Kidney Injury Molecule-1”or “Kim-1” 
and “Acute Kidney Injury”. Specific studies were selected for inclusion if they were published in English journals, in which Kim-1 was measured 
for diagnosis of various forms of Acute Kidney Injury in different articles.  
Results: There were eight articles which met the selection criteria for inclusion in our study. Compared to non acute kidney injury (A KI) 
patients, Kim-1 raised significantly in different forms of AKI patients.  
Conclusions: Kidney Injury Molecule-1 is a new emerging urinary biomarker in the early detection of acute kidney injury and repair of kidney 
cells as well. Kim-1 can detect acute tubular necrosis, a useful marker for renal proximal tubular injury and it can restore morphological 
integration of kidney cells followed by ischemic injury. Kim-1 can detect nephrotoxic injury and injury caused by various drugs as well.  
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INTRODUCTION 
Kidney Injury Moleculr-1(KIM-1) has many characteristics 
that play an important role in clinical diagnosis. Various 
studies revealed that it might be an emerging biomarker of 
acute kidney injury (AKI). Normally, KIM-1 is not present in 
significant amount in normal urine. However, its secretion by 
the kidney cells were raised in acute kidney injury cases. In 
addition to that, its levels were raised during the process of 
repair mechanism as well. These levels persist until kidney 
cells recover from injury completely. 
Conventional blood and urine tests for the diagnosis of 
different types of kidney diseases are insensitive and 
nonspecific. Recent studies elucidated that ectodomain of 
KIM-1 is shed from cells epithelial structures in different 
organs perform diverse and complex tasks but display 
stereotyped responses to injury. The kidney epithelium is 
particularly susceptible to injury due to the character of its 
blood supply and its ability to concentrate many toxins1. 
Injury is revealed by functional deficiencies in handling of 
salts and water, inability to excrete metabolic toxins, and an 
innate inflammatory response 2&3. The damaged segment of 
the nephron can be remodeled, leading to complete 
functional recovery, and as such represents a general model 
of epithelial remodeling after injury. Excretion of apoptotic 
cells and necrotic debris is needed for repair of the tissue 
with restoration of function 4. Excretion of apoptotic cells in 
time has been identified to be a fundamental component of 
developmental remodeling, regulation of appropriate 
immune response, and tissue homeostasis 5.  Furthermore, 
the phagocytic process itself may lead to production of anti-
inflammatory cytokines 6. KIM-1 is not detectable in the 
normal human urine but is raised in expression more than 
any other protein in the injured kidney and is localized 
predominantly to the apical membrane of the surviving 
proximal epithelial cells 7.  
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The purpose of this study is to analyze whether kidney injury 
molecule–1 (KIM-1) plays a significant role in the various 
clinical conditions especially in clinical diagnosis.  
METHODS 
The focus of the current review is to investigate the use of 
kidney injury molecule (KIM-1) in various clinical conditions. 
With this purpose in mind, we were particularly interested 
in papers that reported the use of KIM-1 in clinical diagnosis. 
To ensure the selection of relevant quality articles, we 
restricted our search for published papers in peer-reviewed 
academic journals and excluded conference proceedings, 
book chapters, unpublished manuscripts, dissertations, 
project reports, and position papers. The rationale behind 
such an approach is three-fold. First, the review process for 
publications other than journal papers are normally not that 
rigorous which may, in turn, lead to incomplete review and 
unconvincing conclusions. The journal articles undergo a 
rolling review schedule, with multiple review phases, 
ensuring the findings and conclusions about the reported 
assessments are valid, methodological and comprehensive 8. 
Second, the journal articles are usually longer than 
conference papers and hence present detailed information 
about the assessments. Also, these other types of 
publications are not easy to access and may result in 
asymmetrical studies. Moreover, journal articles provide 
detailed and comprehensive information regarding the 
assessment presented. Although focusing only on journal 
articles allows a consistent and systematic review, this may 
omit some important research work in these publications 
and limit the generalizability of this finding. To gather a 
sufficiently comprehensive corpus for the study, we 
undertook extensive research on a number of available 
sources. This included multiple electronic databases such as 
MEDLINE through 
PUBMED database, EMBASE between January 2016 and 
March 2016 was used. The search was conducted with the 
following search string: Kidney Injury Molecule-1, Acute 
Kidney Injury. Two authors independently screened all 
articles for inclusion.  
RESULTS 
In this section, we present findings from our analysis based 
on the criteria established. We got a total of 8 relevant 
articles.  Urinary Kim-1 measurements are sensitive, specific 
and accurate prediction of nephrotoxicity in drug screens. 
This could enable early identification and elimination of 
compounds that may be nephrotoxic. In addition to that 
there are various clinical conditions where KIM -1 is useful 
to diagnose the disease such as kidney cancer, graft function 
and other kidney diseases. 
In a study conducted by Han WK et al, noted, significant 
expression of KIM-1 in proximal tubule cells in biopsies from 
6 of 6 patients with confirmed ATN. The normalized urinary 
KIM-1 levels were higher in patients with ischemic ATN 
compared to levels in patients with other forms of acute 
renal failure or chronic kidney disease. Levels of other 
urinary markers, consisting of total protein, gamma-
glutamyltransferase, and alkaline phosphatase, did not 
correlate with clinical diagnostic groupings 9. There are 
many studies showing KIM-1 is closely associated with acute 
kidney injury of different types including ATN, Ischemic and 
nephrotoxic cases. 
In another case, forty kidney cancer and 484 non-renal 
tumors were analyzed by immunohistochemistry for 
expression of KIM-1 (group 1). Urine samples before 
nephrectomy and nephrectomy tissue samples were 
sampled from an additional 42 patients with kidney cancers, 
from 30 normal controls and also from 10 patients with 
prostate cancer (group 2). In five additional patients with 
kidney cancer, urine was collected before and after 
nephrectomy (group 3). Tissue was examined for expression 
of KIM-1, and cell-free urine supernatants were screened for 
KIM-1 by Enzyme Linked Immunosorbent Assay (ELISA). 
Urinary KIM-1 was normalized to the urinary creatinine 
concentration. Expression of KIM-1 was present in 32 tissue 
sections (91%) of 35 clear cell RCC (group 1). In group 2, the 
normalized urinary KIM-1 levels were significantly higher in 
patients with clear cell RCC (0.39 ± 0.08 ng/mg ; n = 21), 
compared with levels in patients with prostate carcinoma 
(0.12 ± 0.03 ng/mg ; P < 0.02; n = 10), or normal control 
subjects (0.05 ± 0.01 ng/mg ; P < 0.005; n = 30). Tissue 
sections from 28 (82%) of 34 primary RCC stained positively 
for the expression of KIM-1. In all patients with a detectable 
prenephrectomy urinary KIM-1 level, there was either 
complete disappearance or marked reduction after 
nephrectomy (group 3).  
High KIM-1 excretion was related with proteinuria, low 
creatinine clearance, and high donor age. Urinary excretion 
of KIM-1 is an independent predictor of long-term graft loss 
and therefore a promising new biomarker in early prediction 
of graft loss (10). The above stated studies revealed that the 
Kidney Injury Molecule -1 is a novel emerging diagnostic tool 
in detecting kidney disease earlier then many conventional 
tests. 
DISCUSSION 
The aim of this review was to evaluate the significant of 
plasma or urinary kidney injury molecule-1 (Kim-1). In a 
study conducted by Han WK et al, noted, increased 
expression of KIM-1 in proximal tubule cells in biopsies from 
6 of 6 patients with confirmed acute tubular necrosis (ATN). 
Levels of other urinary markers, consisting of total protein, 
gamma-glutamyltransferase, and alkaline phosphatase, did 
not correlate with clinical diagnostic groupings. They 
revealed that soluble form of human KIM-1 can be detected 
in the urine of patients with Acute Tubular Necrosis (ATN) 
and may serve as a useful marker for kidney proximal tubule 
injury facilitating the early diagnosis of the disease and 
serving as a diagnostic tool 9   Takharu I. et al demonstrated 
in a study revealing structure and expression data signifies 
that the KIM-1 is an epithelial cell adhesion molecule up-
regulated in the cells, which are dedifferentiated and 
undergoing replication. KIM-1 may play an important role in 
the restoration of the morphological integrity and function to 
post ischemic kidney 11. These studies highlight the 
invaluable role of KIM-1 in clinical laboratory medicine. 
In another study, Kim-1 protein was detected in urine of 
toxicant-treated rats. Cisplatin treatment results in early 
detection of urinary Kim-1 protein and diffuse Kim-1 
expression in S3 cells of the proximal tubule of the kidney. 
Kim-1 can be detected in the tissue and urine on day 
1 and 2 after cisplatin administration, occurring before raise 
in serum creatinine. The upregulation of expression of Kim-1 
and its presence in the urine in response to exposure to 
various types of nephrotoxicants revealed that this protein 
may serve as a general marker for tubular injury and repair 
processes 12. 
Therefore, urinary Kim-1 levels can help as a biomarker, 
rapid, sensitive, reproducible, and potentially high-
throughput test to diagnose early kidney injury in studies 
and in preclinical drug development screens for risk-benefit 
profiling of pharmaceutical drugs13. KIM-1 is upregulated in 
renal disease and is associated with renal fibrosis and 
inflammation. Urinary KIM-1 is also associated with 
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inflammation and kidney function, and reflects tissue KIM-1, 
indicating that it can be used as a non-invasive marker in 
kidney disease14.  
Urinary Kim-1 seems to be sensitive and tissue-specific 
markers that will help detection of early acute kidney injury 
following exposure to nephrotoxic 15. 
Raised KIM-1 excretion was related with proteinuria, low 
creatinine clearance, and high donor age. Urinary excretion 
of KIM-1 is an independent predictor of long-term graft loss 
and therefore a promising marker in early prediction of graft 
loss 10. 
 Human kidney injury molecule-1 (KIM-1) is a protein that is 
not detectable in normal kidney tissue but is expressed at 
high levels in human kidneys with dedifferentiated proximal 
tubule epithelial cells after ischemic or toxic injury. 
Therefore, it was hypothesized that renal tumors express 
KIM-1 and release this protein into the urine 16 & 17. 
SUMMARY 
The present systematic review revealed that studies 
evaluating plasma and urinary KIM-1 might play an 
important role in diagnosis of acute kidney injury and repair 
of kidney cells as well. 
Kim-1 can detect acute tubular necrosis, a very good marker 
of kidney proximal tubular injury and it can restore 
morphological integration of kidney cells followed by 
ischemic injury. 
Kim-1 can detect nephrotoxic injury and injury caused by 
various drugs. Kim-1 can detect proteinuria and graft loss. 
Hence Kim- 1 can be used as a new diagnostic marker in the 
diagnosis of different types of kidney diseases including 
kidney cancer. Therefore, kim-1 can be added in Kidney 
function tests to maximize accuracy of the kidney disease. 
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